_id

69171bd63c536f8df2316647

Ticker

TBET

Name

Tibet Pharmaceuticals Inc

Exchange

OTCCE

Address

Room 1701, Wanchai, Hong Kong

Country

USA

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Currency

USD

Website

Description

Tibet Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Tibetan medicines. The company, through its operational entity, Yunnan Shangri-La Tibetan Pharmaceutical Group Limited (YSTP), develops products in China for promoting health in human respiratory, digestive, urinary, and reproductive systems. Its commercialized products include 25 Ingredients Mandrake Pill, which is used to regulate menses to treat endometritis, pelvic inflammations, and women's anemia; 15 Ingredients Gentiana Pill to treat bronchitis, emphysema, asthma, and hoarseness; 28 Ingredients Pinang Pill for treating cold waist hip pain, pus hematuria, and testis swelling; 18 Ingredients Chebulic (Myrobalan) Frusemide Pill for the treatment of kidney problems, lumbar and kidney pain, frequent urination, turbid urine, diabetes, and spermatorrhea; and Pomegranate Nichirin Pill to treat indigestion, back and leg pain, frequent urination, foot edema, impotence, and nocturnal emission. The company also develops Xuezang Guben pill indicated for the treatment of neurasthenia, insomnia, frequent urination, nocturnal emission, and women's menopausal symptoms; Shengke I that is in Phase III clinical testing for treating type II diabetes; Shengke II, which is in Phase II clinical testing for treating impotence and premature ejaculation, prostrate disease, and memory loss; Jiuzan pill that is in Phase II clinical testing for the treatment of chronic gastroenteritis and peptic ulcers; and Antai pill, a pre-clinical stage product for treating hepatitis B. In addition, it focuses to commercialize Wupeng Pill for treating echimococosis, pandora tingling disease, diphtheria, anthrax, yellow water disease, and leprosy. The company was formerly known as Shangri-La Tibetan Pharmaceuticals, Inc. and changed its name to Tibet Pharmaceuticals Inc. in July 2010. Tibet Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Wanchai, Hong Kong.

Last Close

0.0001

Volume

-

Current Price

0.0001

Change

0

Last Updated

2025-12-28T15:00:11.833Z

Image

data:image/webp;base64,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

Ipo Date

2011-01-25T00:00:00.000Z

Market Cap

1484

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-

Sentiment Sources

0

Current Quarter

2011-09-30

Revenue

8582828

Cost Of Revenue

5637715

Gross Profit

2945113

Operating Expenses

6968458

Operating Income

1614370

Interest Expense

3179

Pretax Income

1645975

Net Income

1645975

Eps

-

Dividends Per Share

-

Shares Outstanding

14845834

Income Tax Expense

0

EBITDA

-

Operating Margin

18.80930154955919

Total Other Income Expense Net

31605

Cash

25959333

Short Term Investments

-

Receivables

16012394

Inventories

1740798

Total Current Assets

43745397

Property Plant Equipment

6002200

Total Assets

50220322

Payables

2540874

Short Term Debt

-

Long Term Debt

-

Total Liabilities

3020485

Equity

47199837

Depreciation

353995

Change In Working Capital

-

Cash From Operations

-3786669

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

1

Net Change In Cash

-3559263

PE

0.01

PB

-

ROE

3.4872472123155847

ROA

3.2775078582729917

FCF

-3786669

Fcf Percent

-0.44119129499041576

Piotroski FScore

2

Health Score

43

Deep Value Investing Score

7

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

6.8

Garp Investing Score

2.5

Growth Investing Score

1

Momentum Investing Score

4

Net Net Investing Score

8

Quality Investing Score

6

Value Investing Score

7

Quarters > 0 > quarter

2011-09-30

Quarters > 0 > income Statement > revenue

8582828

Quarters > 0 > income Statement > cost Of Revenue

5637715

Quarters > 0 > income Statement > gross Profit

2945113

Quarters > 0 > income Statement > operating Expenses

6968458

Quarters > 0 > income Statement > operating Income

1614370

Quarters > 0 > income Statement > interest Expense

3179

Quarters > 0 > income Statement > pretax Income

1645975

Quarters > 0 > income Statement > net Income

1645975

Quarters > 0 > income Statement > eps

-

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

-

Quarters > 0 > income Statement > income Tax Expense

0

Quarters > 0 > income Statement > EBITDA

-

Quarters > 0 > income Statement > operating Margin

18.80930154955919

Quarters > 0 > income Statement > total Other Income Expense Net

31605

Quarters > 0 > balance Sheet > cash

25959333

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

16012394

Quarters > 0 > balance Sheet > inventories

1740798

Quarters > 0 > balance Sheet > total Current Assets

43745397

Quarters > 0 > balance Sheet > property Plant Equipment

6002200

Quarters > 0 > balance Sheet > total Assets

50220322

Quarters > 0 > balance Sheet > payables

2540874

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

3020485

Quarters > 0 > balance Sheet > equity

47199837

Quarters > 0 > cash Flow > net Income

1645975

Quarters > 0 > cash Flow > depreciation

353995

Quarters > 0 > cash Flow > change In Working Capital

-

Quarters > 0 > cash Flow > cash From Operations

-3786669

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

1

Quarters > 0 > cash Flow > net Change In Cash

-3559263

Quarters > 0 > ratios > PE

-

Quarters > 0 > ratios > PB

-

Quarters > 0 > ratios > ROE

3.4872472123155847

Quarters > 0 > ratios > ROA

3.2775078582729917

Quarters > 0 > ratios > FCF

-3786669

Quarters > 0 > ratios > Piotroski FScore

2

Quarters > 0 > ratios > fcf Percent

-0.44119129499041576

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2011-06-30

Quarters > 1 > income Statement > revenue

8746125

Quarters > 1 > income Statement > cost Of Revenue

4880369

Quarters > 1 > income Statement > gross Profit

3865756

Quarters > 1 > income Statement > operating Expenses

5243813

Quarters > 1 > income Statement > operating Income

3502312

Quarters > 1 > income Statement > interest Expense

1584

Quarters > 1 > income Statement > pretax Income

3534799

Quarters > 1 > income Statement > net Income

3534799

Quarters > 1 > income Statement > eps

-

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

-

Quarters > 1 > income Statement > income Tax Expense

0

Quarters > 1 > income Statement > EBITDA

-

Quarters > 1 > income Statement > operating Margin

40.044156697966244

Quarters > 1 > income Statement > total Other Income Expense Net

32487

Quarters > 1 > balance Sheet > cash

29518598

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

12400255

Quarters > 1 > balance Sheet > inventories

1255543

Quarters > 1 > balance Sheet > total Current Assets

43174396

Quarters > 1 > balance Sheet > property Plant Equipment

5929331

Quarters > 1 > balance Sheet > total Assets

49915693

Quarters > 1 > balance Sheet > payables

3161182

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

4936717

Quarters > 1 > balance Sheet > equity

44978976

Quarters > 1 > cash Flow > net Income

3534799

Quarters > 1 > cash Flow > depreciation

199430

Quarters > 1 > cash Flow > change In Working Capital

-

Quarters > 1 > cash Flow > cash From Operations

4264138

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

1

Quarters > 1 > cash Flow > net Change In Cash

4702863

Quarters > 1 > ratios > PE

-

Quarters > 1 > ratios > PB

-

Quarters > 1 > ratios > ROE

7.858780511143696

Quarters > 1 > ratios > ROA

7.081538465267827

Quarters > 1 > ratios > FCF

4264138

Quarters > 1 > ratios > Piotroski FScore

4

Quarters > 1 > ratios > fcf Percent

0.48754597035830155

Quarters > 1 > health Score

70

Quarters > 2 > quarter

2011-03-31

Quarters > 2 > income Statement > revenue

8236560

Quarters > 2 > income Statement > cost Of Revenue

4761811

Quarters > 2 > income Statement > gross Profit

3474749

Quarters > 2 > income Statement > operating Expenses

5683680

Quarters > 2 > income Statement > operating Income

2552880

Quarters > 2 > income Statement > interest Expense

1595

Quarters > 2 > income Statement > pretax Income

2565512

Quarters > 2 > income Statement > net Income

2565512

Quarters > 2 > income Statement > eps

-

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

-

Quarters > 2 > income Statement > income Tax Expense

0

Quarters > 2 > income Statement > EBITDA

-

Quarters > 2 > income Statement > operating Margin

30.99449284652816

Quarters > 2 > income Statement > total Other Income Expense Net

12632

Quarters > 2 > balance Sheet > cash

24815733

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

13210313

Quarters > 2 > balance Sheet > inventories

1173443

Quarters > 2 > balance Sheet > total Current Assets

39199489

Quarters > 2 > balance Sheet > property Plant Equipment

6019023

Quarters > 2 > balance Sheet > total Assets

46135904

Quarters > 2 > balance Sheet > payables

3313226

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

5461413

Quarters > 2 > balance Sheet > equity

40674491

Quarters > 2 > cash Flow > net Income

2565512

Quarters > 2 > cash Flow > depreciation

272247

Quarters > 2 > cash Flow > change In Working Capital

-

Quarters > 2 > cash Flow > cash From Operations

2788636

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

14420401

Quarters > 2 > cash Flow > net Change In Cash

17236452

Quarters > 2 > ratios > PE

-

Quarters > 2 > ratios > PB

-

Quarters > 2 > ratios > ROE

6.307422507143359

Quarters > 2 > ratios > ROA

5.560771064548773

Quarters > 2 > ratios > FCF

2788636

Quarters > 2 > ratios > Piotroski FScore

4

Quarters > 2 > ratios > fcf Percent

0.33856804296939497

Quarters > 2 > health Score

67

Quarters > 3 > quarter

2010-12-31

Quarters > 3 > income Statement > revenue

8488600

Quarters > 3 > income Statement > cost Of Revenue

4607531

Quarters > 3 > income Statement > gross Profit

3881069

Quarters > 3 > income Statement > operating Expenses

5363148

Quarters > 3 > income Statement > operating Income

3125452

Quarters > 3 > income Statement > interest Expense

48141

Quarters > 3 > income Statement > pretax Income

3078121

Quarters > 3 > income Statement > net Income

3078121

Quarters > 3 > income Statement > eps

-

Quarters > 3 > income Statement > dividends Per Share

2512000

Quarters > 3 > income Statement > shares Outstanding

-

Quarters > 3 > income Statement > income Tax Expense

0

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

36.81940484885612

Quarters > 3 > income Statement > total Other Income Expense Net

-47331

Quarters > 3 > balance Sheet > cash

7579281

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

12351208

Quarters > 3 > balance Sheet > inventories

1197066

Quarters > 3 > balance Sheet > total Current Assets

21127555

Quarters > 3 > balance Sheet > property Plant Equipment

6166243

Quarters > 3 > balance Sheet > total Assets

28196274

Quarters > 3 > balance Sheet > payables

2877745

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

4714585

Quarters > 3 > balance Sheet > equity

23481689

Quarters > 3 > cash Flow > net Income

3078121

Quarters > 3 > cash Flow > depreciation

30191

Quarters > 3 > cash Flow > change In Working Capital

-

Quarters > 3 > cash Flow > cash From Operations

2765068

Quarters > 3 > cash Flow > capital Expenditures

8271

Quarters > 3 > cash Flow > cash From Investing

-8271

Quarters > 3 > cash Flow > cash From Financing

-3735830

Quarters > 3 > cash Flow > net Change In Cash

-786304

Quarters > 3 > ratios > PE

-

Quarters > 3 > ratios > PB

-

Quarters > 3 > ratios > ROE

13.108601344647738

Quarters > 3 > ratios > ROA

10.916765101658466

Quarters > 3 > ratios > FCF

2756797

Quarters > 3 > ratios > Piotroski FScore

3

Quarters > 3 > ratios > fcf Percent

0.3247646254977264

Quarters > 3 > health Score

76

Annuals > 0 > quarter

2010-12-31

Annuals > 0 > income Statement > revenue

32364975

Annuals > 0 > income Statement > cost Of Revenue

16189532

Annuals > 0 > income Statement > gross Profit

16175443

Annuals > 0 > income Statement > operating Expenses

19049923

Annuals > 0 > income Statement > operating Income

13315052

Annuals > 0 > income Statement > interest Expense

0

Annuals > 0 > income Statement > pretax Income

13142085

Annuals > 0 > income Statement > net Income

13142085

Annuals > 0 > income Statement > eps

-

Annuals > 0 > income Statement > dividends Per Share

2512000

Annuals > 0 > income Statement > shares Outstanding

-

Annuals > 0 > income Statement > income Tax Expense

0

Annuals > 0 > income Statement > EBITDA

-

Annuals > 0 > income Statement > operating Margin

41.140312946325466

Annuals > 0 > income Statement > total Other Income Expense Net

-172967

Annuals > 0 > balance Sheet > cash

7579281

Annuals > 0 > balance Sheet > short Term Investments

-

Annuals > 0 > balance Sheet > receivables

12351208

Annuals > 0 > balance Sheet > inventories

1197066

Annuals > 0 > balance Sheet > total Current Assets

21127555

Annuals > 0 > balance Sheet > property Plant Equipment

6166243

Annuals > 0 > balance Sheet > total Assets

28196274

Annuals > 0 > balance Sheet > payables

2877745

Annuals > 0 > balance Sheet > short Term Debt

-

Annuals > 0 > balance Sheet > long Term Debt

-

Annuals > 0 > balance Sheet > total Liabilities

4714585

Annuals > 0 > balance Sheet > equity

23481689

Annuals > 0 > cash Flow > net Income

13142085

Annuals > 0 > cash Flow > depreciation

901085

Annuals > 0 > cash Flow > change In Working Capital

-

Annuals > 0 > cash Flow > cash From Operations

7851774

Annuals > 0 > cash Flow > capital Expenditures

150101

Annuals > 0 > cash Flow > cash From Investing

-150101

Annuals > 0 > cash Flow > cash From Financing

-4559548

Annuals > 0 > cash Flow > net Change In Cash

3497529

Annuals > 0 > ratios > PE

-

Annuals > 0 > ratios > PB

-

Annuals > 0 > ratios > ROE

55.96737525993126

Annuals > 0 > ratios > ROA

46.60929667515644

Annuals > 0 > ratios > FCF

7701673

Annuals > 0 > ratios > Piotroski FScore

4

Annuals > 0 > ratios > fcf Percent

0.23796319941541744

Annuals > 0 > health Score

82

Annuals > 1 > quarter

2009-12-31

Annuals > 1 > income Statement > revenue

23008031

Annuals > 1 > income Statement > cost Of Revenue

11303118

Annuals > 1 > income Statement > gross Profit

11704913

Annuals > 1 > income Statement > operating Expenses

13592154

Annuals > 1 > income Statement > operating Income

9415877

Annuals > 1 > income Statement > interest Expense

0

Annuals > 1 > income Statement > pretax Income

9244978

Annuals > 1 > income Statement > net Income

9244978

Annuals > 1 > income Statement > eps

-

Annuals > 1 > income Statement > dividends Per Share

8785000

Annuals > 1 > income Statement > shares Outstanding

-

Annuals > 1 > income Statement > income Tax Expense

0

Annuals > 1 > income Statement > EBITDA

-

Annuals > 1 > income Statement > operating Margin

40.92430595212602

Annuals > 1 > income Statement > total Other Income Expense Net

-170899

Annuals > 1 > balance Sheet > cash

4081752

Annuals > 1 > balance Sheet > short Term Investments

98888

Annuals > 1 > balance Sheet > receivables

4710023

Annuals > 1 > balance Sheet > inventories

1305537

Annuals > 1 > balance Sheet > total Current Assets

10196200

Annuals > 1 > balance Sheet > property Plant Equipment

6553113

Annuals > 1 > balance Sheet > total Assets

17952955

Annuals > 1 > balance Sheet > payables

2830032

Annuals > 1 > balance Sheet > short Term Debt

3582116

Annuals > 1 > balance Sheet > long Term Debt

3582116

Annuals > 1 > balance Sheet > total Liabilities

7415759

Annuals > 1 > balance Sheet > equity

10537196

Annuals > 1 > cash Flow > net Income

9244978

Annuals > 1 > cash Flow > depreciation

884687

Annuals > 1 > cash Flow > change In Working Capital

-

Annuals > 1 > cash Flow > cash From Operations

10330239

Annuals > 1 > cash Flow > capital Expenditures

150101

Annuals > 1 > cash Flow > cash From Investing

-150101

Annuals > 1 > cash Flow > cash From Financing

-8972373

Annuals > 1 > cash Flow > net Change In Cash

1370200

Annuals > 1 > ratios > PE

-

Annuals > 1 > ratios > PB

-

Annuals > 1 > ratios > ROE

87.73660469065963

Annuals > 1 > ratios > ROA

51.49557830451867

Annuals > 1 > ratios > FCF

10180138

Annuals > 1 > ratios > Piotroski FScore

3

Annuals > 1 > ratios > fcf Percent

0.4424602000927415

Annuals > 1 > health Score

77

Annuals > 2 > quarter

2008-12-31

Annuals > 2 > income Statement > revenue

15580269

Annuals > 2 > income Statement > cost Of Revenue

7857884

Annuals > 2 > income Statement > gross Profit

7722385

Annuals > 2 > income Statement > operating Expenses

9488309

Annuals > 2 > income Statement > operating Income

6091960

Annuals > 2 > income Statement > interest Expense

0

Annuals > 2 > income Statement > pretax Income

5933483

Annuals > 2 > income Statement > net Income

5933483

Annuals > 2 > income Statement > eps

-

Annuals > 2 > income Statement > dividends Per Share

4244000

Annuals > 2 > income Statement > shares Outstanding

-

Annuals > 2 > income Statement > income Tax Expense

0

Annuals > 2 > income Statement > EBITDA

-

Annuals > 2 > income Statement > operating Margin

39.10048022919245

Annuals > 2 > income Statement > total Other Income Expense Net

-158477

Annuals > 2 > balance Sheet > cash

2711552

Annuals > 2 > balance Sheet > short Term Investments

-

Annuals > 2 > balance Sheet > receivables

3082276

Annuals > 2 > balance Sheet > inventories

1419099

Annuals > 2 > balance Sheet > total Current Assets

7224866

Annuals > 2 > balance Sheet > property Plant Equipment

7231210

Annuals > 2 > balance Sheet > total Assets

15982524

Annuals > 2 > balance Sheet > payables

1515977

Annuals > 2 > balance Sheet > short Term Debt

3569132

Annuals > 2 > balance Sheet > long Term Debt

3569132

Annuals > 2 > balance Sheet > total Liabilities

5912847

Annuals > 2 > balance Sheet > equity

10069677

Annuals > 2 > cash Flow > net Income

5933483

Annuals > 2 > cash Flow > depreciation

787361

Annuals > 2 > cash Flow > change In Working Capital

-

Annuals > 2 > cash Flow > cash From Operations

6187674

Annuals > 2 > cash Flow > capital Expenditures

642112

Annuals > 2 > cash Flow > cash From Investing

-642112

Annuals > 2 > cash Flow > cash From Financing

-4382021

Annuals > 2 > cash Flow > net Change In Cash

1295796

Annuals > 2 > ratios > PE

-

Annuals > 2 > ratios > PB

-

Annuals > 2 > ratios > ROE

58.92426340983926

Annuals > 2 > ratios > ROA

37.12481833282403

Annuals > 2 > ratios > FCF

5545562

Annuals > 2 > ratios > Piotroski FScore

4

Annuals > 2 > ratios > fcf Percent

0.35593493283074895

Annuals > 2 > health Score

78

Valuation > metrics > PE

0.01

Valuation > final Score

70

Valuation > verdict

99.9% Undervalued

Profitability > metrics > ROE

3.4872472123155847

Profitability > metrics > ROA

3.7626244425213473

Profitability > metrics > Net Margin

0.1917753682119693

Profitability > final Score

47

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.06399354726585178

Risk > metrics > Interest Coverage

507.8232148474363

Risk > final Score

100

Risk > verdict

Low

Liquidity > metrics > Current Ratio

17.216673081782094

Liquidity > metrics > Quick Ratio

16.531555283733077

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

50

Prev Valuations > 1

50

Prev Valuations > 2

50

Prev Profitabilities > 0

70

Prev Profitabilities > 1

62

Prev Profitabilities > 2

86

Prev Risks > 0

100

Prev Risks > 1

100

Prev Risks > 2

100

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2026-01-20T22:40:17.401Z

Earnings History > 0 > period

2011-09-30

Earnings History > 0 > report Date

2011-11-14

Earnings History > 0 > date

2011-09-30

Earnings History > 0 > before After Market

-

Earnings History > 0 > currency

USD

Earnings History > 0 > eps Actual

0.11

Earnings History > 0 > eps Estimate

0

Earnings History > 0 > eps Difference

0.11

Earnings History > 0 > surprise Percent

-

Earnings History > 1 > period

2011-06-30

Earnings History > 1 > report Date

2011-08-15

Earnings History > 1 > date

2011-06-30

Earnings History > 1 > before After Market

-

Earnings History > 1 > currency

USD

Earnings History > 1 > eps Actual

0.25

Earnings History > 1 > eps Estimate

0

Earnings History > 1 > eps Difference

0.25

Earnings History > 1 > surprise Percent

-

Earnings History > 2 > period

2011-03-31

Earnings History > 2 > report Date

2011-05-16

Earnings History > 2 > date

2011-03-31

Earnings History > 2 > before After Market

-

Earnings History > 2 > currency

USD

Earnings History > 2 > eps Actual

0.18

Earnings History > 2 > eps Estimate

0

Earnings History > 2 > eps Difference

0.18

Earnings History > 2 > surprise Percent

-

Earnings History > 3 > period

2010-12-31

Earnings History > 3 > report Date

2011-01-18

Earnings History > 3 > date

2010-12-31

Earnings History > 3 > before After Market

-

Earnings History > 3 > currency

USD

Earnings History > 3 > eps Actual

0.32

Earnings History > 3 > eps Estimate

0

Earnings History > 3 > eps Difference

0.32

Earnings History > 3 > surprise Percent

-

Earnings History > 4 > period

2010-09-30

Earnings History > 4 > report Date

2010-12-31

Earnings History > 4 > date

2010-09-30

Earnings History > 4 > before After Market

-

Earnings History > 4 > currency

USD

Earnings History > 4 > eps Actual

0.2606

Earnings History > 4 > eps Estimate

0

Earnings History > 4 > eps Difference

0.2606

Earnings History > 4 > surprise Percent

-